Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Evolocumab, sold under the brand name Repatha, is a monoclonal antibody drug. It is an immunotherapy medication for the treatment of hyperlipidemia.
The analysis highlights History, Community and Culture as prominent areas in the source structure around Evolocumab.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
A focused starting point derived from the topic graph, ranked independently of the source article order.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Evolocumab shows recurring relationship patterns in the source. For example, Evolocumab → Amgen, August, BLA, Canada, Cardiovascular, Europe, FDA, FOURIER, FOURIER-OLE, In, It, Its, March, Results, US Another extracted example is Evolocumab → Amgen, April, AUD, In, In Australia, October, On, One, PBS, Pharmaceutical Benefits Scheme, QALY, The, US. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
amgen pcsk9 patent us antigen target repatha antibody court amgen's fourier per ldl receptors 2023 medication legal type ldl-c patents
TTTA extracted 56 structured relationships around Evolocumab. Examples in this analysis include Evolocumab → AHFS/Drugs.com → Monograph and Evolocumab → ATC code → C10AX13 (WHO). The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Evolocumab | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Evolocumab | ATC code | C10AX13 (WHO) | 1.00 | infobox |
| Evolocumab | CAS Number | 1256937-27-5 | 1.00 | infobox |
| Evolocumab | ChemSpider | none | 1.00 | infobox |
| Evolocumab | Formula | C6242H9648N1668O1996S56 | 1.00 | infobox |
| Evolocumab | KEGG | D10557 Y | 1.00 | infobox |
| Evolocumab | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Evolocumab | Legal status | CA: ℞-only | 1.00 | infobox |
| Evolocumab | Legal status | US: ℞-only | 1.00 | infobox |
| Evolocumab | Legal status | EU: Rx-only | 1.00 | infobox |
| Evolocumab | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Evolocumab | License data | US DailyMed: Evolocumab | 1.00 | infobox |
| Evolocumab | Molar mass | 141790.89 g·mol−1 | 1.00 | infobox |
| Evolocumab | Other names | AMG-145 | 1.00 | infobox |
| Evolocumab | Pregnancy category | AU: B1 | 1.00 | infobox |
| Evolocumab | Pronunciation | e-voe-LOK-ue-mab | 1.00 | infobox |
| Evolocumab | Routes of administration | Subcutaneous | 1.00 | infobox |
| Evolocumab | Source | Human | 1.00 | infobox |
| Evolocumab | Target | PCSK9 | 1.00 | infobox |
| Evolocumab | Trade names | Repatha | 1.00 | infobox |
| Evolocumab | Type | Whole antibody | 1.00 | infobox |
| Evolocumab | UNII | LKC0U3A8NJ | 1.00 | infobox |
The concept neighborhoods around Evolocumab bring nearby vocabulary together. In this analysis, examples include Data, Inhibits and License. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Evolocumab, one of the stronger structural bridges in this analysis connects Evolocumab with History. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Evolocumab to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Community & Culture, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Evolocumab · EN edition · Analysis: TopicsToTalkAbout